BSX
Price
$106.14
Change
-$0.07 (-0.07%)
Updated
Jul 25 closing price
Capitalization
100.1B
87 days until earnings call
NMTC
Price
$0.89
Change
-$0.01 (-1.11%)
Updated
Jul 25 closing price
Capitalization
30.86M
12 days until earnings call
Interact to see
Advertisement

BSX vs NMTC

Header iconBSX vs NMTC Comparison
Open Charts BSX vs NMTCBanner chart's image
Boston Scientific
Price$106.14
Change-$0.07 (-0.07%)
Volume$5.88M
Capitalization100.1B
NeuroOne Medical Technologies
Price$0.89
Change-$0.01 (-1.11%)
Volume$355.14K
Capitalization30.86M
BSX vs NMTC Comparison Chart in %
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. NMTC commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and NMTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BSX: $106.14 vs. NMTC: $0.89)
Brand notoriety: BSX: Notable vs. NMTC: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 75% vs. NMTC: 174%
Market capitalization -- BSX: $100.1B vs. NMTC: $30.86M
BSX [@Medical Specialties] is valued at $100.1B. NMTC’s [@Medical Specialties] market capitalization is $30.86M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileNMTC’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • NMTC’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than NMTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 7 TA indicator(s) are bullish while NMTC’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 7 bullish, 3 bearish.
  • NMTC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BSX is a better buy in the short-term than NMTC.

Price Growth

BSX (@Medical Specialties) experienced а +2.41% price change this week, while NMTC (@Medical Specialties) price change was +3.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

NMTC is expected to report earnings on Dec 10, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than NMTC($30.9M). BSX YTD gains are higher at: 18.831 vs. NMTC (7.350). BSX has higher annual earnings (EBITDA): 3.45B vs. NMTC (-13.34M). BSX has more cash in the bank: 865M vs. NMTC (2.68M). NMTC has less debt than BSX: NMTC (154K) vs BSX (9.49B). BSX has higher revenues than NMTC: BSX (14.2B) vs NMTC (2.82M).
BSXNMTCBSX / NMTC
Capitalization100B30.9M323,625%
EBITDA3.45B-13.34M-25,833%
Gain YTD18.8317.350256%
P/E Ratio63.64N/A-
Revenue14.2B2.82M504,261%
Total Cash865M2.68M32,264%
Total Debt9.49B154K6,163,636%
FUNDAMENTALS RATINGS
BSX vs NMTC: Fundamental Ratings
BSX
NMTC
OUTLOOK RATING
1..100
8139
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
4100
SMR RATING
1..100
70100
PRICE GROWTH RATING
1..100
2844
P/E GROWTH RATING
1..100
48100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NMTC's Valuation (61) in the null industry is in the same range as BSX (85) in the Medical Specialties industry. This means that NMTC’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for NMTC (100) in the null industry. This means that BSX’s stock grew significantly faster than NMTC’s over the last 12 months.

BSX's SMR Rating (70) in the Medical Specialties industry is in the same range as NMTC (100) in the null industry. This means that BSX’s stock grew similarly to NMTC’s over the last 12 months.

BSX's Price Growth Rating (28) in the Medical Specialties industry is in the same range as NMTC (44) in the null industry. This means that BSX’s stock grew similarly to NMTC’s over the last 12 months.

BSX's P/E Growth Rating (48) in the Medical Specialties industry is somewhat better than the same rating for NMTC (100) in the null industry. This means that BSX’s stock grew somewhat faster than NMTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXNMTC
RSI
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
63%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIM14.070.03
+0.21%
Chimera Investment Corp
SIFY5.60N/A
N/A
Sify Technologies Ltd
CNI95.42N/A
N/A
Canadian National Railway
UBSI36.20-0.39
-1.07%
United Bankshares
ECDA0.19-0.04
-15.96%
ECD Automotive Design

NMTC and

Correlation & Price change

A.I.dvisor tells us that NMTC and BSX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NMTC and BSX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMTC
1D Price
Change %
NMTC100%
-1.64%
BSX - NMTC
28%
Poorly correlated
-0.07%
AZTA - NMTC
26%
Poorly correlated
+1.38%
EKSO - NMTC
24%
Poorly correlated
+2.12%
CRL - NMTC
23%
Poorly correlated
-0.10%
TMO - NMTC
23%
Poorly correlated
+0.69%
More